Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension

Respiratory Medicine

Volumn 101, Issue 12, 2007, Pages 2495-2501

  Blyth, Kevin G ^a   Syyed, Raheel ^a   Chalmers, James ^a   Foster, John E ^a   Saba, Tarek ^a   Naeije, Robert ^b   Melot, Christian ^b   Peacock, Andrew J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Mortality; Pulmonary arterial hypertension; Pulse pressure; Survival

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; ILOPROST; OXYGEN; PROSTACYCLIN; SILDENAFIL; UNIPROST; WARFARIN;

ADULT; AGED; ARTERY COMPLIANCE; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; EXERCISE; FEMALE; HEART INDEX; HEART RIGHT VENTRICLE FUNCTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN SATURATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULSE PRESSURE; SURVIVAL RATE; SURVIVAL TIME; SYSTOLIC DYSFUNCTION;

AGED; BLOOD PRESSURE; DIASTOLE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY ARTERY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; SYSTOLE; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 35448982801     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.07.004     Document Type: Article

References (28)

1. Eysmann S.B., Palevsky H.I., Reichek N., Hackney K., and Douglas P.S. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 80 2 (1989) 353-360
2. Kawut S.M., Horn E.M., Berekashvili K.K., Garofano R.P., Goldsmith R.L., Widlitz A.C., et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 95 2 (2005) 199-203
3. Sandoval J., Bauerle O., Palomar A., Gomez A., Martinez-Guerra M.L., Beltran M., et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 89 4 (1994) 1733-1744
4. D'Alonzo G.E., Barst R.J., Ayres S.M., Bergofsky E.H., Brundage B.H., Detre K.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 5 (1991) 343-349
5. Sitbon O., Humbert M., Nunes H., Parent F., Garcia G., Herve P., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40 4 (2002) 780-788
6. Reuben S.R., Swadling J.P., Gersh B.J., Lee Gde J., Reuben S.R., Gersh B.J., et al. Impedance and transmission properties of the pulmonary arterial system. Measurement of pulmonary arterial distensibility in the dog. Cardiovasc Res 5 1 (1971) 1-9
7. Ha B., Lucas C.L., Henry G.W., Frantz E.G., Ferreiro J.I., and Wilcox B.R. Effects of chronically elevated pulmonary arterial pressure and flow on right ventricular afterload. Am J Physiol 267 1 Part 2 (1994) H155-H165
8. van den Bos G.C., Westerhof N., and Randall O.S. Pulse wave reflection: can it explain the differences between systemic and pulmonary pressure and flow waves? A study in dogs. Circ Res 51 4 (1982) 479-485
9. Chae C.U., Pfeffer M.A., Glynn R.J., Mitchell G.F., Taylor J.O., and Hennekens C.H. Increased pulse pressure and risk of heart failure in the elderly. JAMA 281 7 (1999) 634-639
10. Haider A.W., Larson M.G., Franklin S.S., and Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 138 1 (2003) 10-16
11. Vaccarino V., Holford T.R., and Krumholz H.M. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 36 1 (2000) 130-138
12. Franklin S.S., Khan S.A., Wong N.D., Larson M.G., and Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 100 4 (1999) 354-360
13. Millar J.A., Lever A.F., and Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 17 8 (1999) 1065-1072
14. Benetos A., Safar M., Rudnichi A., Smulyan H., Richard J.L., Ducimetieere P., et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30 6 (1997) 1410-1415
15. Galie N., Torbicki A., Barst R., Dartevelle P., Haworth S., Higenbottam T., et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European society of cardiology. Eur Heart J 25 24 (2004) 2243-2278
16. Ganz W., Donoso R., Marcus H.S., Forrester J.S., and Swan H.J. A new technique for measurement of cardiac output by thermodilution in man. Am J Cardiol 27 4 (1971) 392-396
17. Brooks D., Solway S., and Gibbons W.J. ATS statement on six-minute walk test. Am J Respir Crit Care Med 167 9 (2003) 1287
18. Reeves J.T., Linehan J.H., and Stenmark K.R. Distensibility of the normal human lung circulation during exercise. Am J Physiol Lung Cell Mol Physiol 288 3 (2005) L419-L425
19. Krenz G.S., and Dawson C.A. Flow and pressure distributions in vascular networks consisting of distensible vessels. Am J Physiol Heart Circ Physiol 284 6 (2003) H2192-H2203 [Epub 003 Jan 30.]
20. Meyrick B., and Reid L. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab Invest 38 2 (1978) 188-200
21. Emirgil C., Sobol B.J., Campodonico S., Herbert W.H., and Mechkati R. Pulmonary circulation in the aged. J Appl Physiol 23 5 (1967) 631-640
22. Miyamoto S., Nagaya N., Satoh T., Kyotani S., Sakamaki F., Fujita M., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161 2 Part 1 (2000) 487-492
23. Klassen P.S., Lowrie E.G., Reddan D.N., DeLong E.R., Coladonato J.A., Szczech L.A., et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287 12 (2002) 1548-1555
24. Ronnback M., Isomaa B., Fagerudd J., Forsblom C., Groop P.H., Tuomi T., et al. Complex relationship between blood pressure and mortality in type 2 diabetic patients: a follow-up of the Botnia Study. Hypertension 47 2 (2006) 168-173
25. Barst R.J., Rubin L.J., Long W.A., McGoon M.D., Rich S., Badesch D.B., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension study group. N Engl J Med 334 5 (1996) 296-302
26. Frank H., Mlczoch J., Huber K., Schuster E., Gurtner H.P., and Kneussl M. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 112 3 (1997) 714-721
27. Sitbon O., McLaughlin V.V., Badesch D.B., Barst R.J., Black C., Galie N., et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Thorax 60 12 (2005) 1025-1030
28. Mahapatra S., Nishimura R.A., Sorajja P., Cha S., and McGoon M.D. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 47 4 (2006) 799-803